The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription
- PMID: 20019092
- DOI: 10.1093/carcin/bgp317
The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription
Abstract
Tumours of the Ewing family, which comprise Ewing's sarcoma and peripheral primitive neuroectodermal tumours, are highly aggressive and mostly affect children and adolescents. They are characterized by chromosomal translocations leading to the generation of fusion proteins between EWS (or very rarely FUS) and members of the E-twenty-six (ETS) family of transcription factors that are capable of transforming cells. EWS/FLI1, the most frequent fusion, is thought to cause transformation through activation or repression of specific target genes. We present evidence demonstrating that the Wnt inhibitor and beta-catenin/T-cell factor (TCF)-responsive gene DICKKOPF-1 (DKK-1) is a transcriptional target of EWS/FLI1, which can inhibit both basal and beta-catenin-induced transactivation of the DKK-1 promoter. Moreover, our data indicate that EWS/FLI1 has a more general effect on beta-catenin/TCF-mediated transcription since it can block transactivation of a consensus beta-catenin/TCF reporter construct. Consistently, Ewing tumour cells expressing different EWS/ETS translocations cannot engage beta-catenin/TCF-dependent transcription, whereas silencing of EWS/FLI1 restores beta-catenin responsiveness in A673 and RD-ES Ewing tumour cells. Accordingly, gene set enrichment analysis shows that beta-catenin/TCF target genes are significantly enriched among genes downregulated by EWS/FLI1 in the Ewing cell line A673. Mechanistically, the inhibitory effect of EWS/FLI1 can be overcome by a constitutively active TCF4 protein (TCF4-VP16). Moreover, EWS/FLI1 binds lymphoid enhancer factor 1, a TCF family member, and interferes with its binding to beta-catenin, which could explain its negative effect on beta-catenin/TCF-mediated transcription. Our results show that EWS/FLI1 inhibits both DKK-1 expression as well as beta-catenin/TCF-dependent transcription, which could contribute to progression of tumours of the Ewing family.
Similar articles
-
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854. Nat Genet. 1999. PMID: 10508522
-
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.Oncogene. 2008 Oct 9;27(46):6034-43. doi: 10.1038/onc.2008.203. Epub 2008 Jun 30. Oncogene. 2008. PMID: 18591936
-
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.Cancer Res. 1999 Apr 1;59(7):1428-32. Cancer Res. 1999. PMID: 10197607
-
TCFs and Wnt/β-catenin signaling: more than one way to throw the switch.Curr Top Dev Biol. 2012;98:1-34. doi: 10.1016/B978-0-12-386499-4.00001-X. Curr Top Dev Biol. 2012. PMID: 22305157 Review.
-
EWS-ETS oncoproteins: the linchpins of Ewing tumors.Gene. 2005 Dec 19;363:1-14. doi: 10.1016/j.gene.2005.08.007. Epub 2005 Oct 3. Gene. 2005. PMID: 16202544 Review.
Cited by
-
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.Oncotarget. 2016 Aug 30;7(35):56584-56597. doi: 10.18632/oncotarget.10647. Oncotarget. 2016. PMID: 27447745 Free PMC article.
-
BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.PLoS One. 2013;8(3):e59369. doi: 10.1371/journal.pone.0059369. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527175 Free PMC article.
-
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.Cancer Res. 2016 Sep 1;76(17):5040-53. doi: 10.1158/0008-5472.CAN-15-3422. Epub 2016 Jun 30. Cancer Res. 2016. PMID: 27364557 Free PMC article.
-
Advances in sarcoma genomics and new therapeutic targets.Nat Rev Cancer. 2011 Jul 14;11(8):541-57. doi: 10.1038/nrc3087. Nat Rev Cancer. 2011. PMID: 21753790 Free PMC article. Review.
-
Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000471. doi: 10.1101/mcs.a000471. Cold Spring Harb Mol Case Stud. 2015. PMID: 27148571 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous